The medical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential advance. Unlike injections, this approach offers a less invasive way to provide GLP-1 therapies. These https://arunisny009588.livebloggs.com/47740926/glp-1-patches-a-novel-approach-to-diabetes-treatment